Graciela Moya

Rights of persons with conditions associated with disability: Current legal framework.

Graciela Moya, 2017, Archivos argentinos de pediatria.

Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-Limited Settings: Conclusions From the Council for International Organizations of Medical Sciences-Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting.

E. Tarazona-Santos, A. Llerena, E. Terán, 2020, Clinical therapeutics.

The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies

Edwin Cuppen, Claire Redin, Ryan L. Collins, 2016, Nature Genetics.

Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans

R. Barrantes, E. Tarazona-Santos, A. Llerena, 2019, Clinical pharmacology and therapeutics.

The application of the subsidiary principle for patients’ empowerment for health care: the case of rare diseases in Argentina

Graciela Moya, 2012 .

High prevalence of CYP2D6 ultrarapid metabolizers in a mestizo Colombian population in relation to Hispanic mestizo populations.

R. Barrantes, E. Tarazona-Santos, A. Llerena, 2020, Pharmacogenomics.

Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.

R. Barrantes, E. Tarazona-Santos, A. Llerena, 2018, Omics : a journal of integrative biology.

Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America.

E. Tarazona-Santos, A. Llerena, E. Terán, 2016, Pharmacogenomics.